首页> 外国专利> Derivatives of 3,4-dihydro - 2H - 1,4 benzo oxazine and thiazine as CETP inhibitors

Derivatives of 3,4-dihydro - 2H - 1,4 benzo oxazine and thiazine as CETP inhibitors

机译:CETP抑制剂3,4-二氢-2H-[1,4]苯并恶嗪和噻嗪的衍生物

摘要

Pharmaceutical compositions that contain them and uses to prevent or treat coronary heart disease, and as anticolesterol and antilipidemic agents. Claim 1: A compound of formula (1) in which: L is a covalent bond or O; X is O, or S; Q is C6-10 aryl or 5-6 membered heteroaryl, n is 0 to 3; m is from 0 to 3; R1 is C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, 5- or 6-membered heteroaryl, wherein each of the C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, cycloalkyl C3-10, 5- or 6-membered heteroaryl may be optionally substituted; or R1 is phenyl optionally substituted with 1 or 2 members selected from Ra and Rb,where Ra and Rb are independently selected from the group consisting of optionally substituted C1-4 alkyl, halogenated C1-4 alkyl, optionally substituted C2-4 alkenyl, optionally substituted C2-4 alkynyl, C1- alkoxy 4 optionally substituted, halogenated C1-4 alkoxy, optionally substituted C1-4 alkylthio, halo, cyano and hydroxy, or Ra and Rb together with the carbon atoms of the phenyl ring to which they are attached form a heterocyclyl of 5 or 6 members optionally substituted fused to the phenyl ring; each R2 is independently selected from halo, hydroxy, cyano, C1-4 alkoxy, halogenated C1-4 alkoxy, C1-4 alkyl,halogenated C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl and -C (O) H; each R3 is independently selected from C1-4 alkyl, halogenated C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkoxy, halo, cyano and hydroxy; R4 is C1-10 alkyl optionally substituted with 1-3 members independently selected from halo, oxo, hydroxy, halogenated C1-4 alkyl, C1-4 alkoxy, C3-8 cycloalkyl, CN, tert-butyldimethylsilyloxy, substituted heterocyclyl optionally and -NRcRd, where Rc and Rd are independently selected from H, optionally substituted C1-3 alkyl, -C (O) C1-3 alkyl, - C (O) O-C1-3 alkyl, and -SO2 C1-3alkyl,O R4 refers to C1-6 tar, which is replaced by isomerization or phenyl, and consists of 1 to 3 independently selected halogenated, hydroxy, c1-3 tar, c1-3 halogenated tar, alcoxi C1-4 and alcoxi C1-4 halogenated, as well as acceptable salts of dwarfs, diacetylene, ceramics, solutions or drugs.
机译:包含它们的药物组合物,用于预防或治疗冠心病,以及用作抗胆固醇和抗血脂药。 1。式(1)的化合物,其中:L为共价键或O; X是O或S; Q为C6-10芳基或5-6元杂芳基,n为0至3; m为0至3; R 1是C 1-10烷基,C 2-10烯基,C 2-10炔基,C 3-10环烷基,5或6元杂芳基,其中C 1-10烷基,C 2-10烯基,C 2-10炔基,环烷基中的每一个C3-10、5-或6-元杂芳基可以任选地被取代;或R 1是任选地被1个或2个选自Ra和Rb的成员取代的苯基,其中Ra和Rb独立地选自任选取代的C 1-4烷基,卤代C 1-4烷基,任选取代的C 2-4烯基,取代的C2-4炔基,C1-烷氧基4任选取代的卤代C1-4烷氧基,任选取代的C1-4烷硫基,卤素,氰基和羟基,或Ra和Rb以及与它们相连的苯环的碳原子形成5或6个任选取代的稠合至苯环的成员的杂环基;每个R 2独立地选自卤素,羟基,氰基,C 1-4烷氧基,卤代的C 1-4烷氧基,C 1-4烷基,卤代的C 1-4烷基,C 2-4烯基,C 2-4炔基和-C(O)H ;每个R 3独立地选自C 1-4烷基,卤代的C 1-4烷基,C 2-4烯基,C 2-4炔基,C 1-4烷氧基,卤素,氰基和羟基。 R 4是任选地被1-3个独立地选自卤素,氧代,羟基,卤代的C 1-4烷基,C 1-4烷氧基,C 3-8环烷基,CN,叔丁基二甲基甲硅烷氧基,取代的杂环基和-NR cRd的1-3个任选取代的C 1-10烷基,其中R c和R d独立地选自H,任选取代的C 1-3烷基,-C(O)C 1-3烷基,-C(O)O-C 1-3烷基和-SO 2 C 1-3烷基,R 4是到C1-6焦油,其被异构化或苯基取代,并且由1-3个独立选择的卤代,羟基,c1-3焦油,c1-3卤代焦油,alcoxi C1-4和alcoxi C1-4卤代组成作为矮人,二乙炔,陶瓷,溶液或药物的可接受盐。

著录项

  • 公开/公告号AR060904A1

    专利类型

  • 公开/公告日2008-07-23

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA N.V.;

    申请/专利号AR2007P102055

  • 发明设计人

    申请日2007-05-11

  • 分类号C07D265/34;C07D413/04;C07D413/10;A61K31/538;A61K31/5377;A61P9/10;A61P3/10;A61P3/04;

  • 国家 AR

  • 入库时间 2022-08-21 20:08:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号